Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;64(1):62-8.
doi: 10.4103/0301-4738.178146.

Does tight control of systemic factors help in the management of diabetic retinopathy?

Ramachandran Rajalakshmi, Vijayaraghavan Prathiba, Viswanathan Mohan  1
Affiliations
Review

Does tight control of systemic factors help in the management of diabetic retinopathy?

Ramachandran Rajalakshmi et al. Indian J Ophthalmol. 2016 Jan.

Abstract

Diabetic retinopathy (DR), one of the leading causes of preventable blindness, is associated with many systemic factors that contribute to the development and progression of this microvascular complication of diabetes. While the duration of diabetes is the major risk factor for the development of DR, the main modifiable systemic risk factors for development and progression of DR are hyperglycemia, hypertension, and dyslipidemia. This review article looks at the evidence that control of these systemic factors has significant benefits in delaying the onset and progression of DR.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Chennai Urban Rural Epidemiological Study: Prevalence of retinopathy based on quartiles of glycated hemoglobin levels
Figure 2
Figure 2
Fenofibrate Intervention and Event Lowering in Diabetes study-effect of fenofibrate on the need for laser photocoagulation for diabetic retinopathy
See this image and copyright information in PMC

Comment in

References

    1. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64. - PMC - PubMed
    1. World Health Organization. Global Initiative for the Elimination of Avoidable Blindness. WHO/PBL/97.61 Rev 2. 2006. [Last accessed on 2016 Jan 05]. Available from: http://www.who.int/blindness/Vision2020_report.pdf .
    1. Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a South Indian type 2 diabetic population – The Chennai urban rural epidemiology study (CURES) eye study 4. Diabet Med. 2008;25:536–42. - PubMed
    1. Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology. 2009;116:311–8. - PubMed
    1. Aiello LP, Cahill MT, Wong JS. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol. 2001;132:760–76. - PubMed

MeSH terms